Non ST Segment Elevation Acute Coronary Syndrome
22
3
4
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
4.5%
1 terminated out of 22 trials
85.7%
-0.8% vs benchmark
32%
7 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (22)
Individual Patient Data Meta-analysis on Prehospital Risk Assessment in Patients Suspected of Non-ST-segment Elevation Acute Coronary Syndrome
Pre Hospital Triage of Patients at Intermediate and High Risk for ACS
MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients
Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation
Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study
COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)
Angio-based Final Functional Effect of PCI
Differential Diagnosis and Risk Stratification in Patients With Suspected NSTEACS
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy
HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS
Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling
In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes?
EKG Criteria and Identification of Acute Coronary Occlusion
Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI
Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS